Lantern Pharma Inc.
LTRN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $8,389 | $6,061 | $6,378 | $7,511 |
| Short-Term Investments | $3,973 | $9,840 | $13,344 | $16,502 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,098 | $1,299 | $1,102 | $1,235 |
| Total Curr. Assets | $13,461 | $17,201 | $20,823 | $25,248 |
| Property Plant & Equip (Net) | $129 | $183 | $236 | $287 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $37 | $37 | $37 | $37 |
| Total NC Assets | $166 | $220 | $273 | $324 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13,627 | $17,420 | $21,096 | $25,572 |
| Liabilities | – | – | – | – |
| Payables | $3,946 | $4,753 | $4,125 | $0 |
| Short-Term Debt | $94 | $132 | $162 | $191 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $4,140 |
| Total Curr. Liab. | $4,040 | $4,884 | $4,286 | $4,331 |
| LT Debt | $0 | $14 | $33 | $53 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $14 | $33 | $53 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $145 | $195 | $244 |
| Total Liabilities | $4,040 | $4,898 | $4,320 | $4,384 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$89,071 | -$84,893 | -$80,562 | -$76,026 |
| AOCI | $40 | $48 | $132 | $154 |
| Other Equity | $98,616 | $97,367 | $97,206 | $97,058 |
| Total Equity | $9,587 | $12,522 | $16,776 | $21,188 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13,627 | $17,420 | $21,096 | $25,572 |
| Net Debt | -$8,296 | -$5,916 | -$6,183 | -$7,267 |